Day: February 13, 2024

BURLINGTON, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops,...

SASKATOON, Saskatchewan, Feb. 13, 2024 (GLOBE NEWSWIRE) — BHP and YWCA Saskatoon are pleased to announce a $500,000 investment from BHP to YWCA’s Hope Lives Here campaign. In 2022, YWCA Saskatoon’s Crisis Shelter & Residence turned away a staggering 4,253 women and children in need. Hope Lives Here is the organization’s largest capital campaign ever. With a fundraising goal of $19 million, the campaign is funding a new transitional housing wing that will more than double YWCA Saskatoon’s capacity to provide women and children with a safe place to stay. It will also contribute to funding much needed existing facility repairs and renovations. BHP’s investment will go toward YWCA Saskatoon’s Employment and Learning Centre, a place where clients have access to programs and services that help them obtain sustainable employment....

PRESS RELEASE Wolters Kluwer CCH® Tagetik expert solution wins four Dresner Advisory Services Technology Innovation AwardsCCH® Tagetik recognized for its ESG reporting solution in new award category New York – February 13, 2024 – Wolters Kluwer, a global leader in professional information, software solutions and services, today announced that its CCH® Tagetik expert solution has been named as a winner in four categories in the 2023 Technology Innovation Awards from Dresner Advisory Services. The four awards recognize CCH Tagetik for its capabilities across:Supply Chain Planning and Analytics Environment, Social and Governance Reporting (ESG) Financial Consolidation, Close Management and Financial Reporting (FCCR) Sales Performance Management.Ralf Gärtner, Senior Vice President and General Manager of Corporate Performance & ESG,...

TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) — via IBN — Nextech3D.ai (OTCQX: NEXCF) (CSE: NTAR) (FSE: 1SS), a Generative AI-Powered 3D model supplier for Amazon, P&G, Kohl’s and other major e-commerce retailers is thrilled to announce a significant $1.8 million 3D modeling contract with a major enterprise client. This deal provides significant revenue for the Company to be delivered in 2024, and showcases Nextech3D.ai’s position as an industry leader for 3D modeling in the $6.3 trillion e-commerce market.[1] Nextech3D.ai CEO Evan Gappelberg commented, “Nextech3D.ai has been at the forefront of the massive shift from 2D static images to 3D immersive experiences, utilizing augmented reality and cutting-edge generative AI technology to create photo-realistic 4K 3D models that cater to the specific needs of...

Temenos is leading the transition to a more sustainable banking industry with Software-as-a-Service GENEVA, Switzerland, Feb. 13, 2024 (GLOBE NEWSWIRE) — Temenos (SIX: TEMN) has been recognized again as a global sustainability leader according to the most reputable ESG ratings. The company achieved the top score in the Software industry for the second year running in the 2023 Dow Jones Sustainability Indices (DJSI) and was the only company in the industry awarded top 1% distinction in the S&P Global Sustainability Yearbook for 2024. Temenos was also classified as low risk in Sustainalytics ESG Risk Rating Report, while retained its platinum medal by EcoVadis for its sustainability performance. These latest achievements reflect Temenos’ commitment to sustainability as the company leads the transition to SaaS, with more than...

Company continues to make strides towards breakeven NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to $15.2M in 2023, an increase of 60% year over year. Both pathology and products divisions have demonstrated substantial growth from 2023, with the pathology services division increasing revenue by 52%, and the products division increasing revenue by 115%. The growth of revenues in both of these divisions, alongside the cost-cutting measures executed by the company during 2023, has driven the substantial reduction in cash burn from operations, as was recently reported. With a $1.5M cash balance ending 2023, the company is positioned to achieve its goal of reaching profitability. “Continued...